1. Home
  2. ANF vs SUPN Comparison

ANF vs SUPN Comparison

Compare ANF & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abercrombie & Fitch Company

ANF

Abercrombie & Fitch Company

HOLD

Current Price

$91.37

Market Cap

4.4B

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$50.06

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANF
SUPN
Founded
1892
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
2.8B
IPO Year
1996
2010

Fundamental Metrics

Financial Performance
Metric
ANF
SUPN
Price
$91.37
$50.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
5
Target Price
$120.83
$61.60
AVG Volume (30 Days)
1.0M
477.9K
Earning Date
05-27-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
10.46
N/A
Revenue
$5,266,292,000.00
$392,755,000.00
Revenue This Year
$5.10
$22.72
Revenue Next Year
$3.83
$18.10
P/E Ratio
$8.91
N/A
Revenue Growth
6.42
N/A
52 Week Low
$65.45
$29.16
52 Week High
$133.11
$59.68

Technical Indicators

Market Signals
Indicator
ANF
SUPN
Relative Strength Index (RSI) 46.44 44.63
Support Level $84.12 $49.46
Resistance Level $93.00 $52.25
Average True Range (ATR) 4.31 1.51
MACD 0.47 0.01
Stochastic Oscillator 25.67 24.22

Price Performance

Historical Comparison
ANF
SUPN

About ANF Abercrombie & Fitch Company

Abercrombie & Fitch Co is a digitally led, omnichannel retailer offering apparel, personal care products, and accessories for men, women, and kids through company-owned stores, digital channels, and third-party arrangements. The company operates through three geographic segments: Americas, the maximum revenue generator; Europe, the Middle East and Africa (EMEA); and Asia-Pacific (APAC). Its brand families include Abercrombie brands and Hollister brands. The Americas segment covers North and South America, EMEA includes Europe, the Middle East and Africa, and APAC includes the Asia-Pacific region, including Asia and Oceania.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: